Journal News

Journal of Lipid Research launches junior associate editors program

ASBMB Today Staff
April 1, 2019

This year, the Journal of Lipid Research welcomes its first cohort of junior associate editors.

Raymond Blind Raymond Blind
Vanderbilt University
School of Medicine
Research area: Nuclear lipid signaling and structure
Mentor: George Carman

Gissette Reyes-Sofer Gissette Reyes−Soffer
Columbia University
Irving Medical Center
Research area: Regulation and metabolism of Lipoprotein(a)
Mentor: Henry Ginsberg

Brandon Davies Brandon Davies
University of Iowa
Carver College of Medicine
Research area: Lipid metabolism in endothelial cells
Mentor: Stephen Young 

Rotonya Carr Rotonya Carr
University of Pennsylvania Perelman School of Medicine
Research area: Metabolism and lipid droplets in liver disease
Mentor: Nick Davidson

The four assistant professors, chosen from nominations made by the journal’s associate editors, are partnering with senior editors to learn how to manage the peer-review process.

“Engagement with the best and brightest young investigators in the lipid field is an investment in the future of JLR,” Co-Editor-in-Chief Kerry−Anne Rye said.

The new editors — two Ph.D.s and two M.D.s — already have accrued accolades and earned the community’s trust. Two are recipients of the JLR Junior Investigator Award. One won the Journal of Biological Chemistry/Herb Tabor Young Investigator Award. Another is on the Deuel Conference board.

Co-Editor-in-Chief Nicholas Davidson said the program’s mission is two-fold: “It’s demystifying the peer-review process and also teaching what we hope are going to be the next generation of full associate editors.”

The new editors are serving a two-year term from March 1, 2019, to Feb. 28, 2021.

They also will contribute a new type of article to the journal — commentaries on exciting lipid research published elsewhere.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.